Goodwin has advised the investor Gilde Healthcare on the financing of the acquisition of the medical technology manufacturer Koscher & Würtz ("K&W"). The parties have agreed not to disclose the financial details of the transaction.
Following the acquisition of Chr. Diener in 2022, the acquisition of Koscher & Würtz is another important step for Gilde Healthcare on its way to forming a group of leading contract manufacturers of surgical instruments.
Koscher & Würtz will operate as a group company alongside Chr. Diener and together employ around 300 highly qualified employees. By joining forces, K&W and Chr. Diener will be able to offer their customers an even broader product portfolio while benefiting from the exchange of know-how and best practices. The joint vision is to create a leading contract manufacturer of precision medical instruments.
Koscher & Würtz is a manufacturer of precision surgical hand instruments and develops and manufactures reusable and disposable surgical instruments. Founded in 1983, K&W has developed into a leading company in its market niche. The continuous focus on quality and customer satisfaction has resulted in long-term customer relationships and has allowed the company to grow with its customers.
Gilde Healthcare is an investor specializing in the healthcare sector that manages more than 2.6 billion euros in two fund strategies: Venture & Growth and Private Equity. Gilde Healthcare's Venture & Growth fund invests in fast-growing digital health, medtech and therapeutics companies based in Europe and North America. Gilde Healthcare's private equity fund invests in profitable mid-market healthcare companies based in Northwest Europe.
The Goodwin team was led by partner Winfried M. Carli and associate Daniel Wagner (both Private Equity/Finance, Munich) and included associate Philipp Lauer (Tax, Munich) and transaction lawyer Rina Omura (Private Equity/Finance, Munich).